UNIVERSAL HEALTH REALTY INCOME TRUST

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations $21.1m $15.4m $19.2m $17.6m
Net Income (Loss) Attributable to Parent $17.2m $45.6m $24.2m $19.0m $19.4m $109.2m $21.1m $15.4m $19.2m $17.6m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $17.2m $24.2m $19.0m $19.4m $109.2m $21.1m $15.4m $19.2m $17.6m
Depreciation, Depletion and Amortization $23.0m $25.1m $24.8m $25.7m $25.6m $27.5m $26.6m $27.7m $27.4m $28.9m
Amortization of Debt Issuance Costs $764k $791k $714k $729k $765k $762k
Amortization of Intangible Assets $5.1m $4.9m
Depreciation $17.4m $19.7m $20.5m $21.8m $21.8m $23.9m $23.3m $24.6m $24.5m $26.0m
Depreciation Amortization Depletion $26.4m $27.6m $27.2m $28.7m
Share-based Payment Arrangement, Noncash Expense $481k $538k $571k $702k $912k $947k $780k $780k $853k $936k
Income (Loss) from Equity Method Investments $4.5m $2.4m $1.8m $1.8m $1.7m $1.8m $1.2m $1.2m $1.3m $1.7m
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $87.3m ($232k)
Operating Lease, Expense $460k $474k $480k $480k $508k $611k $666k $692k $723k
Additional Financial Items
Payments of Financing Costs $307k $446k $1.7m $35k $467k $1.8m $26k $222k $2.4m $35k
Beginning Cash Position $22.5m $7.6m $8.2m $7.1m
Cash Flow From Continuing Financing Activities ($25.0m) ($23.2m) ($34.1m) ($34.5m)
Cash Flow From Continuing Investing Activities ($36.7m) ($19.1m) ($13.9m) ($15.0m)
Change In Accrued Expense $1.1m ($199k) ($105k) $2.3m
Change In Interest Payable $27k $117k $204k $216k
Change In Other Working Capital $723k $728k $947k $1.1m
Change In Payables And Accrued Expense $1.1m ($199k) ($105k) $2.3m
Change In Receivables ($2.1m) ($513k) ($760k) ($458k)
Change In Working Capital ($228k) $16k $82k $3.0m
Changes In Account Receivables ($2.1m) ($513k) ($760k) ($458k)
Changes In Cash ($14.9m) $598k ($1.1m) ($411k)
End Cash Position $7.6m $8.2m $7.1m $6.7m
Financing Cash Flow ($25.0m) ($23.2m) ($34.1m) ($34.5m)
Free Cash Flow $46.8m $42.9m $46.9m $49.1m
Gain Loss On Investment Securities ($87.3m) $232k
Investing Cash Flow ($36.7m) ($19.1m) ($13.9m) ($15.0m)
Issuance Of Capital Stock $215k $177k $147k $156k
Net Business Purchase And Sale ($94k) ($4.1m) ($5.9m) ($6.8m)
Net PPE Purchase And Sale $15.1m ($13.6m) ($3.7m)
Operating Gains Losses ($87.3m) $232k
Other Non Cash Items ($1.3m) ($1.1m) ($503k) ($1.1m)
Purchase Of Business ($94k) ($4.1m) ($5.9m) ($6.8m)
Purchase Of PPE $60.4m $9.0m $4.1m $5.1m $2.3m ($13.0m) ($13.6m) ($7.6m) $7.6m $7.6m
Repurchase Of Capital Stock $0 $0 ($131k)
Sale Of PPE $28.1m $0 $3.9m
Stock Based Compensation $780k $780k $853k $936k
Net Cash Provided by (Used in) Operating Activities $40.7m $46.0m $42.9m $42.7m $44.2m $47.7m $46.8m $42.9m $46.9m $49.1m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $60.4m $9.0m $4.1m $5.1m $2.3m $13.0m $13.6m $7.6m
Payments to Acquire Investments $5.5m $532k $820k $2.1m $3.2m $16.8m $94k $4.1m $5.9m $6.8m
Net Investment Properties Purchase And Sale ($36.1m) ($19.3m) ($9.1m) ($8.8m)
Purchase Of Investment Properties ($36.1m) ($23.2m) ($9.1m) ($8.8m)
Gains (Losses) on Sales of Investment Real Estate $2.0m
Sale Of Investment Properties $0 $3.9m $0 $0
Net Other Investing Changes ($5.8m) ($1.3m) $3.5m
Net Cash Provided by (Used in) Investing Activities ($74.8m) $39.5m ($8.0m) ($16.5m) ($27.2m) ($24.4m) ($36.7m) ($19.1m) ($13.9m) ($15.0m)
Cash flows from financing activities:
Issuance Of Debt $26.2m $28.5m $22.3m $7.3m
Long Term Debt Issuance $26.2m $28.5m $22.3m $7.3m
Net Issuance Payments Of Debt $14.0m $16.6m $8.8m $6.4m
Net Long Term Debt Issuance $14.0m $16.6m $8.8m $6.4m
Net Short Term Debt Issuance $35.7m $26.2m $28.5m
Short Term Debt Issuance $35.7m $26.2m $28.5m
Long Term Debt Payments ($12.2m) ($11.9m) ($13.6m) ($940k)
Repayment Of Debt ($12.2m) ($11.9m) ($13.6m) ($940k)
Common Stock Issuance $215k $177k $147k $156k
Net Common Stock Issuance $177k $147k ($131k) $156k
Payments for Repurchase of Common Stock $221k $235k
Common Stock Payments $0 $0 ($131k)
Dividends paid $35.1m $36.1m $36.8m $37.4m $38.0m $38.5m $39.2m $39.8m $40.4m $41.0m
Cash Dividends Paid ($39.2m) ($39.8m) ($40.4m) ($41.0m)
Common Stock Dividend Paid ($39.2m) ($39.8m) ($40.4m) ($41.0m)
Dividends Received CFI $875k $757k $1.1m $683k
Net Other Financing Charges ($26k) ($222k) ($2.4m) ($35k)
Net Cash Provided by (Used in) Financing Activities $34.1m ($86.0m) ($33.3m) ($25.1m) ($17.4m) ($6.5m) ($25.0m) ($23.2m) ($34.1m) ($34.5m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1.6m $1.1m ($368k) $16.8m ($14.9m) $598k ($1.1m) ($411k)
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($14.9m) $598k ($1.1m) ($411k)
Interest Paid, Excluding Capitalized Interest, Operating Activities $8.9m $9.7m $9.5m $10.0m $7.6m $8.1m $10.4m $16.3m $17.9m $17.9m